BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 4581340)

  • 1. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 2. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
    Swann JP
    Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769
    [No Abstract]   [Full Text] [Related]  

  • 3. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 4. Two centuries of assessing drug risks.
    Avorn J
    N Engl J Med; 2012 Jul; 367(3):193-7. PubMed ID: 22808954
    [No Abstract]   [Full Text] [Related]  

  • 5. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 6. Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate.
    Daemmrich A
    Pharm Hist; 2003; 45(1):3-17. PubMed ID: 12691078
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Federal drug and narcotic legislation.
    Young JH
    Pharm Hist; 1995; 37(2):59-67. PubMed ID: 11639645
    [No Abstract]   [Full Text] [Related]  

  • 9. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 10. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of drug use and drug control.
    Fox DM
    Mt Sinai J Med; 1991 Oct; 58(5):403-5; discussion 437-42. PubMed ID: 1753976
    [No Abstract]   [Full Text] [Related]  

  • 12. Food and Drug Administration: 100 years of protection.
    Mosocco DJ
    Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
    [No Abstract]   [Full Text] [Related]  

  • 13. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 14. Sure cure: public policy on drug efficacy before 1962.
    Swann JP
    Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897
    [No Abstract]   [Full Text] [Related]  

  • 15. A century of ensuring safe foods and cosmetics.
    Meadows M
    FDA Consum; 2006; 40(1):6-13. PubMed ID: 16528821
    [No Abstract]   [Full Text] [Related]  

  • 16. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FDA ten years after the Kefauver-Harris amendments.
    Hollister LE
    Perspect Biol Med; 1974; 17(2):243-9. PubMed ID: 4591497
    [No Abstract]   [Full Text] [Related]  

  • 18. The goose that laid the golden capsule, part I.
    Smith BE
    Tenn Med; 2005 May; 98(5):224-5. PubMed ID: 15934531
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA law enforcement: critical to product safety.
    Rados C
    FDA Consum; 2006; 40(1):21-7. PubMed ID: 16528823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.